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Newly Diagnosed Juvenile Idiopathic Arthritis and Childhood Antibiotic Use 
Abstract 
Background: Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children and can be 
life-altering. The etiology of JIA is unknown, though current research focuses on a combination of genetic 
factors, immune mechanisms, and environmental triggers. Evidence has shown a genetic predisposition 
to JIA, but this only accounts for a portion of JIA cases. That leaves environmental triggers and immune 
mechanisms. One environmental trigger being investigated is childhood antibiotic exposure and has 
already been implicated in the pathogenesis of certain autoimmune diseases like type 1 diabetes and 
Crohn disease. The goal of this paper is to examine the relationship between newly diagnosed JIA and 
childhood antibiotic exposure. 
Methods: An exhaustive search using MEDLINE-Ovid, MEDLINE-PubMed, and Web of Science was 
performed using the keywords: juvenile idiopathic arthritis and antibiotic exposure. The resulting studies 
were then screened for eligibility criteria. Once screened, the remaining studies were then thoroughly 
assessed and appraised for quality of evidence using The Grading of Recommendations Assessment, 
Development, and Evaluation (GRADE) guidelines. 
Results: Two studies were included in this systematic review, meeting both inclusion and exclusion 
criteria. The first study was a case-control study which looked at 1298 cases and 5179 appropriate 
controls in Finland. Researchers found that the risk of JIA increased with the number of antibiotic 
purchases, with antibiotic groups lincosamides and cephalosporins showing the strongest association 
with JIA. Lastly, overall exposure to antibiotics before 2 years of age was associated with an increased 
risk of JIA. Another case-control study looked at 152 cases and 1520 appropriate controls in the UK and 
concluded that any antibiotic exposure was associated with an increased risk of developing JIA and was 
dose-dependent, with the relationship strongest within 1 year of diagnosis. These findings did not change 
when adjusting for the number or type of infections. In addition, antibiotic-treated upper respiratory 
infections (URIs) were more strongly associated with JIA than untreated URIs. 
Conclusion: Clinically, this research provides utility for providers seeing younger patients receiving 
frequent antibiotics for infections. It could be a possible recommendation that providers screen these 
patients more frequently for signs and symptoms of JIA because of the association shown in the 
research presented in this analysis. Further research needs to be conducted in order to truly uncover the 
association between antibiotic exposure and JIA and the etiology of JIA and its specific categories. 
Future studies should also be conducted to follow patients for a longer period of time. 
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Abstract   
 
Background: Juvenile idiopathic arthritis (JIA) is the most common 
type of arthritis in children and can be life-altering. The etiology of JIA 
is unknown, though current research focuses on a combination of 
genetic factors, immune mechanisms, and environmental triggers. 
Evidence has shown a genetic predisposition to JIA, but this only 
accounts for a portion of JIA cases. That leaves environmental triggers 
and immune mechanisms. One environmental trigger being 
investigated is childhood antibiotic exposure and has already been 
implicated in the pathogenesis of certain autoimmune diseases like 
type 1 diabetes and Crohn disease. The goal of this paper is to 
examine the relationship between newly diagnosed JIA and childhood 
antibiotic exposure.  
 
Methods:  An exhaustive search using MEDLINE-Ovid, MEDLINE-
PubMed, and Web of Science was performed using the keywords: 
juvenile idiopathic arthritis and antibiotic exposure. The resulting 
studies were then screened for eligibility criteria. Once screened, the 
remaining studies were then thoroughly assessed and appraised for 
quality of evidence using The Grading of Recommendations 
Assessment, Development, and Evaluation (GRADE) guidelines. 
 
Results: Two studies were included in this systematic review, meeting 
both inclusion and exclusion criteria. The first study was a case-control 
study which looked at 1298 cases and 5179 appropriate controls in 
Finland. Researchers found that the risk of JIA increased with the 
number of antibiotic purchases, with antibiotic groups lincosamides 
and cephalosporins showing the strongest association with JIA. Lastly, 
overall exposure to antibiotics before 2 years of age was associated 
with an increased risk of JIA. Another case-control study looked at 152 
cases and 1520 appropriate controls in the UK and concluded that any 
antibiotic exposure was associated with an increased risk of developing 
JIA and was dose-dependent, with the relationship strongest within 1 
year of diagnosis. These findings did not change when adjusting for 
the number or type of infections. In addition, antibiotic-treated upper 
respiratory infections (URIs) were more strongly associated with JIA 
than untreated URIs.  
 
Conclusion:  Clinically, this research provides utility for providers 
seeing younger patients receiving frequent antibiotics for infections. It 
could be a possible recommendation that providers screen these 
patients more frequently for signs and symptoms of JIA because of the 
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association shown in the research presented in this analysis. Further 
research needs to be conducted in order to truly uncover the 
association between antibiotic exposure and JIA and the etiology of JIA 
and its specific categories. Future studies should also be conducted to 
follow patients for a longer period of time. 
 
Keywords: juvenile idiopathic arthritis and antibiotic exposure  
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Newly Diagnosed Juvenile Idiopathic Arthritis 
and Childhood Antibiotic Exposure 
BACKGROUND 
Juvenile idiopathic arthritis is the most common type of arthritis 
in children and depending on the specific type, has the potential to be 
debilitating.1 For example, for systemic type JIA, about 50% of cases 
develop short stature (<95th percentile) in adulthood. Overall, about 
30% of people with JIA have significant functional limitations 10 or 
more years after onset.2 The etiology of JIA is poorly understood. 
Current research suggests a complex interaction between genetic 
factors, immune mechanisms, and environmental triggers. Evidence 
for a genetic contribution to JIA comes from family studies3 that 
indicate a 15-30 times higher prevalence of JIA among siblings of JIA 
patients than in the general population. Most of the genetic 
contribution to JIA is thought to be from the major histocompatibility 
complex (MHC) loci, with specific alleles lending themselves to 
predisposing individuals to a specific type of JIA.4 
Environmental factors contributing to JIA have been more 
difficult to identify, and although some genetic component is present in 
all types of JIA, the environmental component has shown to be 
stronger in some types.4 One of the environmental factors under 
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investigation is antibiotic use. There is current evidence to suggest 
that childhood antibiotic use creates an imbalance in the gut 
microbiome, setting off an immune response, which could then be 
responsible for the development of autoimmune diseases such type I 
diabetes,5 Crohn disease,6 and JIA. This is a relatively new body of 
research looking at the effects of childhood antibiotic use because 
these subjects are part of the first generation to have frequent 
antibiotic exposure as infants and children, and researchers can now 
look at the effects of that use. In JIA specifically, it is possible this 
immune response results in the known pathophysiology of JIA in which 
invasion of the synovial tissue of joints by inflammatory cells recruited 
from the peripheral circulation result in the inflamed synovial tissue 
and subsequent joint damage.4 The goal of this paper is to examine 
the relationship between newly diagnosed JIA and childhood antibiotic 
exposure.  
METHODS 
An exhaustive literature search was performed using MEDLINE-
Ovid, MEDLINE-PubMed, and Web of Science. The following keywords 
were used in this search: “juvenile idiopathic arthritis” and “antibiotic 
exposure” and both inclusion and exclusion criteria were applied. 
Included were studies with patients diagnosed with JIA, evaluating the 
role of antibiotics leading up to that diagnosis. Other inclusion criteria 
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were studies less than 5 years old, human-only studies, and studies 
written in English. Exclusion criteria included studies that evaluated 
other immune-modulated diseases and studies evaluating other 
medication besides antibiotics. The quality of relevant articles was 
evaluated using the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) Working Group guidelines.  
RESULTS 
The initial search yielded 14 articles, and through deletion of 
duplicates and screening with eligibility criteria, the search was 
narrowed down to 2 articles. Both articles were case-control studies7,8 
(See Table 1.)   
Arvonen et al 
The first study7 was done in 2014 in Finland. This is a case-
control study whose objective was to explore whether childhood 
antibiotic exposure would be associated with the risk of developing 
JIA. To do this, researchers collected data from national registers 
containing all children born in Finland from 2000-2010 and diagnosed 
with JIA by the end of December 2012 (n=1298) and controls 
(n=5179) matched for age, sex, and place of birth. The diagnosis of 
JIA was based on information from a special reimbursement system in 
which patients with JIA received reimbursement for anti-rheumatic 
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drugs, glucocorticoids, and immunosuppressant drugs. In order to 
receive this special reimbursement, a patient’s condition and diagnosis 
has to be verified by a pediatric rheumatologist. During the time 
period of this study, 99% of the special reimbursement applications 
were approved, and the approval process took about 2 weeks. In 
addition to diagnosis of JIA and the reimbursement, the register also 
contained information regarding the presence of other chronic diseases 
(eg, asthma).7 
To evaluate for antibiotic exposure, researchers extracted 
information on all antibiotics for systemic use purchased for the study 
for children from birth until diagnosis of JIA (the starting date of the 
special reimbursement was used as the date of diagnosis). For the 
control children, antibiotic exposure was recorded from birth to index 
date of the respective JIA case.7 
In this study, purchase of one or more antibiotics from birth to 
index date was associated with an increased risk of JIA (OR 1.6, 95% 
CI 1.3-1.9). Antibiotic groups lincosamides and cephalosporins showed 
the strongest association with JIA (OR 6.6, 95% CI 3.7-11.7, and OR 
1.6, 95% CI 1.4-1.8 respectively). This study also looked at exposure 
to antibiotics in different age ranges, and found that antibiotic use 
during the first 6 months of life was not significant, but the purchase 
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of one or more antibiotics in the first 12 months of life was associated 
with an increased risk of JIA (OR 1.2, 95% CI 1.2-1.6), and any 
exposure (0 vs. any) in the first 24 months was also associated with 
an increased risk of JIA (OR 1.4, 95% CI 1.2-1.6). There was a risk of 
JIA associated with the number of purchases of any antibiotics and 
separately for specific antibiotics.7 
Horton et al 
The second case-control study8 is more recent, done in 2015 in 
the UK. This study cites the first study7 in its references, and attempts 
to build on it. This study’s objective was to test the hypothesis that 
childhood antibiotic exposure was associated with newly diagnosed 
JIA, and to also further examine a time- and dose-dependent 
relationship, as well as control for infection and other variables. In 
order to do this, researchers used a population-representative 
electronic medical records database from over 550 practices of general 
practitioners across the UK. Data within this database were collected 
during patient visits and the information made anonymous for 
research purposes. Data included demographic characteristics, 
diagnoses, referrals, and outpatient prescriptions. Subjects ranged 
from 1-15 years of age of those registered in the database within 3 
months of birth. Children with previous inflammatory bowel disease 
(IBD), immunodeficiency, or non-JIA systemic rheumatic diseases 
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were excluded. Ten control subjects without inclusion or exclusion 
diagnoses were matched according to the age and gender to each case 
subject, making a total of 1520 controls and 152 cases. Control 
subjects were randomly selected from practices containing at least 1 
subject with JIA, to help alleviate the possibility of lack of practitioner 
awareness about JIA. The study period was from registration in the 
database to the index date (date of first JIA code).8 
To evaluate for antibiotic exposure, systemic antibiotics 
prescribed by general practitioners were sorted according to type, 
date, and dose. Additional analyses were performed to examine 
antianaerobic vs. non-antianaerobic and specific antibiotic class. 
Antibiotics were also classified by the presence of enterohepatic 
circulation, the thinking being that these antibiotics may have a 
greater effect on the gut microbiome. Antiviral and antifungal agents 
were also analyzed for comparison with antibacterial agents. This 
study also evaluated the effect of timing of the first and last antibiotic 
exposure during the study period. To consider confounding by 
infection, researchers compared the risk of development of JIA with 
antibiotic-treated URIs and untreated URIs.8 
In the results of this study, any antibiotic use was associated 
with newly diagnosed JIA (OR 2.1 95% CI 1.2-3.5) in a dose- and 
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time-dependent manner. The time of the first exposure of antibiotics 
did not appear to have an effect, but the relationship between 
antibiotic exposure and incident JIA diagnosis was strongest when 
antibiotic exposure occurred within one year prior to diagnosis. No 
differences in risk were associated with specific antibiotic categories. 
Also, antiviral and antifungal medication exposure was not associated 
with an increased risk of JIA. Having multiple antibiotic-treated URIs 
was strongly associated with JIA while untreated URIs were not. An 
association with treated URIs persisted after excluding cases of acute 
otitis media, pharyngitis, and sinusitis.8  
DISCUSSION 
Both studies’ results support the hypothesis that antibiotic 
exposure is associated with an increased risk of developing JIA. In the 
first study,7 there was an upward trend in the odds ratio for more 
frequent purchases of antibiotics. The same phenomenon was found in 
the second study:8 a dose-dependent relationship between the number 
of antibiotic purchases and the risk of JIA. JIA is the most common 
childhood arthritis. Current incidence estimates range from 6.6-15 
cases of JIA per 100 000 children.9 Though the risk of development of 
JIA with antibiotic use may not be high enough to negate the use of 
antibiotics in infections in the pediatric population, this relationship 
may be important for clinicians to screen for JIA in those children who 
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have repeated exposure to antibiotics and to be judicious in 
prescribing antibiotic therapy to only those that need it. Additionally, 
with the Arvonen et al study7 indicating an increased risk with the type 
of antibiotic prescribed (eg, lincosamides having an OR of 6.6), 
clinicians may be inclined to avoid those antibiotics especially in 
children 2 years old and younger.  
Along with the evidence, there were some limitations. One 
limitation of the first study7 was that it did not differentiate the effects 
of antibiotic use from the effects of infection. It is important to 
distinguish these two entities when looking at the association; is the 
antibiotic use associated with incident diagnosis of JIA because of 
disruption of the microbiome or do these patients have a type of 
inherent abnormality of their immune system which therefore 
predisposes them to infection and therefore the prescription for 
antibiotics? Or, is there a shared susceptibility to infections and JIA, a 
link that has yet to be discovered? In the second study,8 though 
researchers did try to control for infection, other factors such as 
demographic variables, comorbidities, previous infections, maternal 
autoimmunity, and hospitalization could have been confounders. 
Another issue to bring up with both studies7,8 is the presence of 
chronic disease and the disproportionate presence in the case 
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subjects. In the first study,7 asthma was more prevalent in the case 
group and children with a diagnosis of asthma had more purchases of 
antibiotics than those without asthma (13.4 vs. 5.3 purchases, 
difference 8.1, CI 7.3-8.9). In the second study8, psoriasis and uveitis 
were more prevalent in the case subjects. Case subjects also had more 
history of infection, hospitalization for infection, and more infections 
than control subjects. Cases also had more outpatient visits and 
mothers of case subjects were nearly twice as likely to have 
autoimmune diseases.  
The evidence presented in these two studies7,8 provides another 
avenue of exploration in the potential dangers of antibiotic use and 
also the etiology of JIA. But, due to the limitations of these studies, 
further studies need to be conducted. These should include a more 
representative population with a longer duration of study, an 
examination the specific categories of JIA, further differentiation of 
antibiotic use from infection and other confounders in the pathogenesis 
of JIA, and an evaluation of the risk of each antibiotic category.   
CONCLUSION 
Antibiotic exposure in children may play a role in the 
pathogenesis of JIA. If this is the case, antibiotics may be the first part 
of the cascade that results in JIA, and is thus a potential modifiable 
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risk factor in the development of the disease. Though the risk of 
development of JIA with antibiotic use may not be high enough to 
negate the use of antibiotics in infections in the pediatric population, 
this relationship may be important for clinicians to screen for JIA in 
those children who have repeated exposure to antibiotics. Given the 
very low quality of evidence in both studies,7,8 further clinical studies 
will need to be conducted in order to build upon the preliminary 
evidence of these two studies.   
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Table 1: Quality Assessment of Reviewed Articles, GRADE Profile: JIA and 
Childhood Antibiotic Exposure 
Study Design 
Downgrade Criteria 
Upgrade 
Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision 
Publication 
bias 
Arvonen 
et al7 
Case-
Control 
Seriousa Not Serious Not Serious Not Serious Unlikely Dose-
Response 
Gradientb 
Very 
Low 
Horton 
et al8 
Case-
Control 
Seriousc Not serious Not Serious Not Serious Unlikely Dose-
Response 
Gradientd 
Very 
Low 
GRADE: Grading of Recommendations, Assessments, Development, and Evaluation 
a Failure to adequately control confounding (infection), and differences in case and control subjects (chronic 
diseases) 
b Overall purchases of any antibiotics from birth to diagnosis was associated with an increased risk of JIA, with an 
association of increased risk of JIA and the number of purchases analyzed for any antibiotics 
c Differences in case and control subjects (previous autoimmunity, hx of infection, hospitalization for infection, 
number of outpatient visits, etc.) 
d Receipt of ≥ 1 antibiotic prescription was associated with an increased risk of developing JIA, the magnitude of 
the association increased with additional antibiotic courses 
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